Evidence mapPaperPMID 34716910Full record

ArticleHormones (Athens, Greece)2022

Serum adipokine levels in patients with type 1 diabetes are associated with degree of obesity but only resistin is independently associated with atherosclerosis markers.

Erieta Kollari, Ioanna Zografou, Christos Sampanis, Vasilios G Athyros, Triantafyllos Didangelos, Christos S Mantzoros, Asterios Karagiannis

Abstract read
PubMed Publisher
In one paragraph

Article in Hormones (Athens, Greece), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. The Role of Adipokines in Inflammatory Mechanisms of Obesity.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Erieta Kollari2nd Propedeutic Department of Internal Medicine, Aristotle University, Konstantinoupoleos 49, Thessaloniki, Greece. erietakollari@hotmail.com.ORCID http://orcid.org/0000-0001-9351-1923
Ioanna Zografou2nd Propedeutic Department of Internal Medicine, Aristotle University, Konstantinoupoleos 49, Thessaloniki, Greece.
Christos Sampanis2nd Propedeutic Department of Internal Medicine, Aristotle University, Konstantinoupoleos 49, Thessaloniki, Greece.
Vasilios G Athyros2nd Propedeutic Department of Internal Medicine, Aristotle University, Konstantinoupoleos 49, Thessaloniki, Greece.
Triantafyllos Didangelos1st Propedeutic Department of Internal Medicine, Aristotle University, Thessaloniki, Greece.
Christos S MantzorosDivision of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Asterios Karagiannis2nd Propedeutic Department of Internal Medicine, Aristotle University, Konstantinoupoleos 49, Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRBeth Israel Deaconess Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe role of adipokines in causing inflammation and insulin resistance in normal weight and obese patients is generally well studied. However, there are often conflicting results regarding their levels in type 1 diabetes mellitus (T1DM) patients and their relationship to micro- and macrovascular disease. We therefore investigated which serum adipokine levels are independently associated with markers of early atherosclerosis and microvascular complications in patients with T1DM.

methodsA cross-sectional study was performed in the Diabetes Outpatient Clinic of Hippokrateion General Hospital, Thessaloniki, Greece. Sixty T1DM patients (30 females, mean age 38.8 ± 10.6 years, mean diabetes duration 17.4 ± 9.9 years) were included. Plasma adiponectin, leptin, and resistin, carotid artery intima media thickness (cIMT), and arterial stiffness (pulse wave velocity, PWV/SpygmoCor CP System and Mobil-O-Graph 24 h PWA) were assessed.

resultsLeptin and resistin levels were significantly higher in overweight and obese patients (p = 0.002 and p = 0.039, respectively). Adiponectin was the only adipokine negatively correlated with BMI (r

conclusionsSerum adipokine levels demonstrate similar bivariate associations with anthropometric variables in patients with T1DM to those in normal weight subjects. Although microvascular complications are associated with serum adipokine levels by bivariate analysis, only resistin, an inflammatory marker, is independently associated with arterial stiffness in patients with T1DM.

Indexed as

AtherosclerosisDiabetes Mellitus, Type 1AdipokinesAdiponectinAdultCarotid Intima-Media ThicknessCross-Sectional StudiesFemaleHumansLeptinMaleMiddle AgedObesityPulse Wave AnalysisResistinAdipokinesAdiponectinLeptinResistinAdiponectincIMTLeptinPWVResistin

Identifiers

PMID34716910
OpenAlexW3210895009

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.